2021

1. An Fc-free EGFR-specific 4-1BB-agonistic trimerbody displays broad antitumor activity in humanized murine cancer models without toxicity

   Clinical Cancer Research, Vol. 27, Núm. 11, pp. 3167-3177

2. CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation

   Nature Communications, Vol. 12, Núm. 1